Nuzenio

Yahoo Finance Abcellera

Yahoo Finance Abcellera news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 3 publisher sources 100/100 entity strength

Latest news

AbCellera stock surges on ABCL635 menopause Phase 2 trial results - Yahoo FinanceYahoo Finance · Tue, 11 Aug 2026 13:16:37 GMT Is AbCellera Biologics (ABCL) Fully Valued After Its 172% Run? - Yahoo! Finance CanadaYahoo! Finance Canada · Tue, 11 Aug 2026 10:10:00 GMT Why Did ABCL, REPL, ABNB Stocks Hit 52-Week Highs Today? - Yahoo FinanceYahoo Finance · Tue, 11 Aug 2026 02:31:00 GMT AbCellera’s ABCL-635 Cuts Menopause Hot Flashes 83% in Phase II Trial - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 13:03:44 GMT AbCellera shares surge 22% after ABCL635 delivers positive Phase 2 results - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 12:45:25 GMT AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 11:00:00 GMT AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026 - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 20:30:00 GMT AbCellera Biologics Inc (8QQ.MU) stock price, news, quote and history - au.finance.yahoo.comau.finance.yahoo.com · Thu, 06 Aug 2026 17:30:00 GMT

Timeline

Tue, 11 Aug 2026 13:16:37 GMTAbCellera stock surges on ABCL635 menopause Phase 2 trial results - Yahoo Finance

Tue, 11 Aug 2026 10:10:00 GMTIs AbCellera Biologics (ABCL) Fully Valued After Its 172% Run? - Yahoo! Finance Canada

Tue, 11 Aug 2026 02:31:00 GMTWhy Did ABCL, REPL, ABNB Stocks Hit 52-Week Highs Today? - Yahoo Finance

Mon, 10 Aug 2026 13:03:44 GMTAbCellera’s ABCL-635 Cuts Menopause Hot Flashes 83% in Phase II Trial - Yahoo Finance

Mon, 10 Aug 2026 12:45:25 GMTAbCellera shares surge 22% after ABCL635 delivers positive Phase 2 results - Yahoo Finance

Mon, 10 Aug 2026 11:00:00 GMTAbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile - Yahoo Finance

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Yahoo Finance Yahoo9 live mentions Finance9 live mentions Phase6 live mentions ABCL6 live mentions AbCellera5 live mentions Vertex4 live mentions AbCellera Biologics Inc3 live mentions Reports3 live mentions Fully Valued After2 live mentions Its2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Yahoo Finance Abcellera.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.